¥35,467
All-inclusive package total · per person
Who this package is for
The definitive men’s programme: full laboratory and imaging work-up, pan-tumour markers, brain MRI/MRA, bone density, cytokine profiling and same-day gastroscopy and colonoscopy with sedation, plus a dedicated urinary-tract and prostate cancer block.
What's included
Consultation & Physical Examination
- Pre-consultation with a physician — A review of your past medical history, family history, surgery and lifestyle habits, with personalised screening advice.
- Vital signs assessment — Height, weight, BMI, blood pressure and pulse rate.
- Internal medicine examination — Cardiopulmonary, abdominal, dorsalis pedis artery, lower-limb oedema and renal assessment.
- Surgical examination — Skin, lymph nodes, thyroid, breasts, bones and joints.
- Body composition analysis — Segmental fat, muscle mass and visceral-fat estimates used to track metabolic and nutritional status.
Laboratory Tests
- Complete blood count (CBC) — Screening for anemia, infection and hematological disorders.
- Urinalysis — Screening for urinary tract infection, hematuria, proteinuria and metabolic disease.
- Stool routine — Microscopy of stool for occult blood, parasites and digestive abnormalities.
- Renal function panel (3 items) — Urea, creatinine and uric acid: kidney excretory function, protein metabolism and gout risk.
- Electrolyte panel (6 items) — Sodium, potassium, chloride, calcium, phosphorus and magnesium balance.
- Liver function panel — ALT, AST, total protein, albumin, prealbumin, total and direct bilirubin, total bile acids, GGT, ALP and ferritin.
- Total cholesterol — Overall blood cholesterol; a core cardiovascular risk marker.
- Triglycerides — Blood-fat level; part of cardiovascular and metabolic risk assessment.
- LDL cholesterol (LDL-C) — The main atherogenic cholesterol and a primary target for cardiovascular risk management.
- HDL cholesterol (HDL-C) — The protective fraction; higher levels are favourable for the cardiovascular system.
- Hepatitis C antibody (anti-HCV) — Screening for current or past hepatitis C infection.
- Syphilis specific antibody test — Screening for syphilis infection; part of pre-endoscopy infection screening.
- HIV antibody test — Screening for HIV infection; part of pre-endoscopy infection screening.
- Coagulation panel (9 items) — PT activity and ratio, INR, fibrin degradation products, D-dimer, fibrinogen, APTT and thrombin time; required before endoscopy.
- 12-lead resting ECG — Detects arrhythmia, myocardial ischemia and previous infarction.
- HbA1c — Average blood sugar over the past three months; a key diabetes indicator.
- Fasting glucose — Blood sugar on an empty stomach; initial diabetes screening.
- Insulin and C-peptide — Assesses pancreatic beta-cell function and insulin resistance alongside glucose.
- High-sensitivity C-reactive protein (hs-CRP) — Detects low-grade vascular inflammation and refines cardiovascular risk prediction.
- Homocysteine — Independent risk marker for cardiovascular and cerebrovascular disease.
- Apolipoprotein A1 (ApoA1) — The main structural protein of HDL; used with ApoB for the ApoB/ApoA1 risk ratio.
- Apolipoprotein B (ApoB) — Reflects the number of atherogenic particles; a sharper cardiovascular risk marker than LDL-C alone.
- Lipoprotein(a) — Genetically determined cardiovascular risk marker.
- Lactate dehydrogenase (LD) — Non-specific marker of tissue turnover and haemolysis.
- Alpha-hydroxybutyrate dehydrogenase (α-HBD) — Cardiac- and liver-related enzyme fraction.
- Creatine kinase (CK) + CK-MB — Muscle and cardiac-muscle enzymes; screens for muscle injury and myocardial damage.
- Thyroid panel (9 items) — T3, FT3, T4, FT4, TSH, thyroglobulin, TgAb, TRAb and TPOAb.
- Calcitonin — Screening marker for medullary thyroid carcinoma.
- 25-hydroxyvitamin D — Assessment of vitamin D status relevant to bone and immune health.
- Anemia panel (6 items) — Iron stores, folate and vitamin B12 status plus related indices behind anemia and fatigue.
- Interleukin-2 (IL-2) — Cytokine marker reflecting T-cell immune activity.
- Interleukin-4 (IL-4) — Cytokine marker reflecting Th2-type immune response.
- Interleukin-6 (IL-6) — Inflammatory cytokine linked to chronic inflammation and immune dysregulation.
- Interleukin-8 (IL-8) — Chemokine involved in neutrophil recruitment and inflammatory response.
- Interleukin-10 (IL-10) — Anti-inflammatory cytokine, read with the wider cytokine profile.
- Immune cell analysis — Lymphocyte subsets and counts used to gauge cellular immune function.
Tumor Markers & Infection Screening
- Epstein–Barr virus antibody panel — EBV infection status, relevant to nasopharyngeal carcinoma risk.
- Epstein–Barr virus DNA (EBV-DNA) — Viral load marker used with the EBV antibody panel in nasopharyngeal screening.
- Liver triple-marker panel — AFP together with the AFP-L3/AFP ratio and the AFP heterogeneity marker (TP-Ab).
- Des-gamma-carboxy prothrombin (PIVKA-II) — Sensitive marker for hepatocellular carcinoma.
- Alpha-L-fucosidase (AFU) — Enzyme marker supporting liver-cancer screening.
- CEA — Broad-spectrum marker for colorectal, pancreatic and gastric cancer, plus lung and breast cancer.
- CA 125 — Screening and monitoring marker for ovarian and other gynecologic tumors.
- CA 19-9 — Screening and monitoring marker for pancreatic and colorectal cancer.
- CA 72-4 — Gastric and ovarian cancer marker; useful alongside CEA and CA 19-9.
- Tumour-specific growth factor (TSGF) — Broad-spectrum serum marker used as a supplementary screen.
- Tumour necrosis factor alpha (TNF-α) — Inflammatory cytokine relevant to tumour and immune surveillance.
- Cytokeratin 19 fragment (CYFRA21-1) — Non-small-cell lung cancer marker.
- Pro-gastrin-releasing peptide (ProGRP) — Serum marker for small-cell lung cancer.
- Neuron-specific enolase (NSE) — Marker for small-cell lung cancer and neuroendocrine tumours.
- Squamous cell carcinoma antigen (SCC) — Marker for squamous-cell cancers including cervical, lung and oesophageal.
- Gastrin-17 (G-17) — Reflects gastric mucosal atrophy and gastric-cancer risk.
- Pepsinogen I & II (PG I, PG II) — Serological markers of gastric mucosal atrophy.
- Total prostate-specific antigen (TPSA) — Primary prostate-cancer screening marker.
- Free prostate-specific antigen (FPSA) — Read with total PSA to refine prostate-cancer risk.
- Nuclear matrix protein 22 (NMP22) — Urine marker for urothelial (bladder) cancer.
- Complement factor H / bladder tumour antigen (BTA) — Urine marker supporting urothelial tumour screening.
- Cystatin C — Estimate of kidney filtration that is less affected by muscle mass than creatinine.
- Multi-sample urine tumour screening (kidney, urothelium, prostate) — Combined urine assays for urinary-tract malignancy.
- Urine microalbumin (quantitative) — Early marker of diabetic and hypertensive kidney damage.
- Hepatitis B panel (5 items, quantitative) — Infection status plus protective antibody titre.
- C-13 urea breath test — Detects Helicobacter pylori infection, closely linked to gastric cancer.
- Fecal occult blood test — Screening for occult gastrointestinal bleeding.
- Low-dose chest CT — Low-dose CT for early detection of pulmonary nodules and lung cancer.
Imaging & Function Tests
- Abdominal ultrasound (liver, gallbladder, pancreas, spleen, kidneys) — Imaging of the hepatobiliary, splenic, pancreatic and renal systems.
- Thyroid & lymph node ultrasound — Imaging of thyroid nodules and cervical lymph nodes.
- Urinary tract ultrasound (ureters & bladder) — Kidneys, ureters and bladder.
- Bilateral carotid artery ultrasound — Carotid stenosis and plaque — a major stroke risk factor.
- Echocardiogram — Cardiac structure, valves and systolic function.
- Brain MRI — Structural imaging of the brain for silent lesions, atrophy and vascular change.
- Non-contrast brain MR angiography — Assesses the intracranial arteries for stenosis and aneurysm without contrast.
- Pancreatic MRI — Dedicated pancreatic imaging for cystic and solid lesions.
- Amylase — Pancreatic and salivary enzyme, read together with pancreatic imaging.
- QCT bone density (quantitative CT) — Volumetric bone-mineral density of the spine; more sensitive than plain DXA.
Endoscopy & Anaesthesia
- Gastroscopy — Direct endoscopic examination of the oesophagus, stomach and duodenum.
- Colonoscopy — Direct endoscopic examination of the colon and terminal ileum.
- Anaesthesia specialist assessment — Pre-procedure review and consultation before sedation.
- Non-intubated intravenous general anaesthesia — Sedation for a comfortable, pain-free endoscopy.
- Anaesthesia monitoring during endoscopy — Continuous monitoring of vital signs throughout the procedure.
Value-added Services
- Breakfast — Provided after the fasting items are complete.
- Medical report — A written summary of every finding with the physician’s interpretation.
- Post-checkup GP consultation & report review — A physician walks you through the report and the follow-up plan.
How Your Visit Goes
- Arrive at the Precision Health Promotion Centre reception; your coordinator handles registration and interpretation.
- Complete your blood and urine sampling first, then move through imaging and specialist examinations in one streamlined visit.
- Meet the attending physician to review your preliminary findings and agree on any follow-up.
- Receive your full bilingual report within 24–72 hours, with a coordinating physician on hand to walk you through it.
Other packages at Arion Cancer Center
Arion Targeted · Cancer Screening (Men)
¥4,927- Consultation & Physical Examination
- Laboratory Tests
- Tumor Markers & Infection Screening
- Imaging & Function Tests
Arion Targeted · Cancer Screening (Women)
¥6,412- Consultation & Physical Examination
- Laboratory Tests
- Tumor Markers & Infection Screening
- Imaging & Function Tests
Arion Executive · Major Disease Risk Assessment (Women)
¥12,516- Consultation & Physical Examination
- Laboratory Tests
- Tumor Markers & Infection Screening
- Imaging & Function Tests
- Women’s Health
Arion Executive · Major Disease Risk Assessment (Men)
¥12,336- Consultation & Physical Examination
- Laboratory Tests
- Tumor Markers & Infection Screening
- Imaging & Function Tests
Arion Select · Chronic Disease Risk Assessment (Women)
¥14,252- Consultation & Physical Examination
- Laboratory Tests
- Tumor Markers & Infection Screening
- Imaging & Function Tests
- Women’s Health
Arion Select · Chronic Disease Risk Assessment (Men)
¥12,321- Consultation & Physical Examination
- Laboratory Tests
- Tumor Markers & Infection Screening
- Imaging & Function Tests
Arion Signature · Comprehensive Health Assessment (Women)
¥36,992- Consultation & Physical Examination
- Laboratory Tests
- Tumor Markers & Infection Screening
- Imaging & Function Tests
- Women’s Health
- Endoscopy & Anaesthesia
Indicative pricing. Prices are the centre’s published programme totals and are confirmed in writing by your coordinator before you commit. Every programme listed here is a fixed all-inclusive package — no per-item charges, no surprise add-ons.